Trial Profile
A Double-Blind, Randomized Study to Compare Onabutuliumtoxin A Versus Kenalog for Intravaginal Trigger Point Injections in the Treatment of Chronic Pelvic Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Ropivacaine; Triamcinolone
- Indications Muscle pain; Pelvic pain; Spasm
- Focus Therapeutic Use
- 22 Oct 2018 Status changed from active, no longer recruiting to completed.
- 15 Sep 2018 Planned End Date changed from 1 Jul 2018 to 1 Jan 2019.
- 27 Mar 2018 Planned End Date changed from 1 May 2018 to 1 Jul 2018.